The Valley Desk

ArticleFrontiers in oncologyPublished

Multi-parameter optimization of a novel anti-TROP2 MMAE antibody-drug-conjugate for solid tumor therapy

16 of 47 authors shown in byline order.

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source

Institution
Merck & Co.

Publication record

Type
Article
Venue
Frontiers in oncology
Published
Subject terms
Hydrophobicity; Monoclonal antibody; Solid Tumors; Trop2; Mmae; Avidity Tuning; Stable Linker; Antibody-drug-conjugate
PubMed ID
42877637
Added to directory
Source checked

Report a correction or request removal